Where blue sky research breaks through the clouds.
We place exceptional graduates inside European labs to turn dormant research into the deep tech companies of the next decade.
Graduates leave Europe's best universities fascinated by science, technology, and the idea of building something that matters. Then they look at their options: consulting, corporate, finance. They choose the safe path, not because they love it, but because no structured alternative exists.
Rutger Bregman called it the Bermuda Triangle of Talent: society's brightest minds disappearing into work that creates little value for the world.
European universities produce some of the world's best research. Yet the vast majority never reaches the market. Transfer offices are overwhelmed. Brilliant discoveries sit in drawers because nobody has the time, the mandate, or the commercial instinct to bring them out.
The IP is there. The talent is there. What's missing is the bridge.
A twelve-month fellowship that embeds exceptional graduates inside university labs. They scout dormant IP, validate market potential, and prepare spin-outs. Three exits, every outcome a win: spin out a company, transition to a PhD, or leave with experience few people ever get.
The Institute has something different for each of you.
You want to build something real.
A twelve-month fellowship embedded inside a university lab. Scout IP. Validate. Spin out, continue as a PhD, or move on with experience that sets you apart.
Fellowship details →You have IP. We bring commercial co-founders.
We send you talented, commercially minded researchers. They work in your labs, publish papers, and explore spin-out potential. You fund half the salary. We handle the rest.
Partnership details →Patient capital for patient science.
Non-profit structure. Early cohorts funded by foundations and grants. Over a decade, minority equity returns from spin-outs compound into a self-funding flywheel.
Funding model →In formation, 2026. Talking with TU Berlin, TransferAllianz, and SPRIND. First pilot cohort planned for Q4 2026.